Navigation Links
Olympus Introduces the World's Only Integrated Bipolar and Ultrasonic Energy Platform
Date:3/20/2012

CENTER VALLEY, Pa., March 20, 2012 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced FDA clearance of its revolutionary THUNDERBEAT hand instruments and universal surgical platform.

(Photo:  http://photos.prnewswire.com/prnh/20120320/PH73718 )

THUNDERBEAT is the world's only surgical device that combines advanced bipolar and ultrasonic energies into a single multi-functional hand instrument allowing surgeons to simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread. Additionally, it boasts the fastest cutting speed, delivers reliable vessel sealing, and provides the highest grasping forces at the tip when compared to the leading energy instruments currently on the market.

"This is a significant advancement in surgical energy instrument technology," stated Charlie Goodwin, Group Vice President of Olympus' Surgical Business. "Previously, surgeons had to choose between the benefits of bipolar or ultrasonic energy when selecting an advanced energy instrument. THUNDERBEAT eliminates that difficult decision by combining both energies into a single multi-functional instrument," added Goodwin.

THUNDERBEAT, when combined with the versatility of the ESG-400 electrosurgical generator, is the only surgical tissue management system that delivers every common form of energy used in surgery today (monopolar, bipolar, ultrasonic and advanced bipolar) as well as the revolutionary combination of advanced bipolar and ultrasonic energies. This will appeal to hospital administrators interested in the cost savings associated with standardizing on a single energy platform as it could reduce the number of discrete systems required in any given surgical procedure. Additionally, THUNDERBEAT includes a standard 5-year warranty within the U.S. only.

"Our aim as a leading global healthcare company is to advance medical and surgical techniques and minimally invasive procedures, through the development of inspiring technological solutions and innovative products like THUNDERBEAT, that overcome the day-to-day constraints that physicians and surgeons face," said Luke Calcraft, President of Olympus Corporation of the Americas' Medical Systems Group. "Olympus is committed to helping physicians and surgeons perform advanced procedures that elevate the standards of patient care and deliver better treatment, while improving outcomes and enhancing quality of life," continued Calcraft.

THUNDERBEAT joins Olympus' extensive portfolio of surgical energy devices and hand instruments.  It is the world's only platform that combines advanced bipolar and ultrasonic energies into a single, multi-functional hand instrument, allowing surgeons to rapidly and simultaneously seal and cut vessels up to and including 7 mm in size with minimal thermal spread.

THUNDERBEAT hand instruments can be used in Open, Laparoscopic (including Single-Site surgery) General Surgery, Urologic Surgery, Gynecologic Surgery, Thoracic Surgery, Plastic and Reconstructive Surgery, Bowel Resection, Cholecystectomy, Nissen Fundoplication, Adhesiolysis, Oophorectomy, Hysterectomy (both vaginally assisted and abdominal) and Endoscopic Surgery, or in any procedure in which cutting, vessel ligation (sealing and cutting), coagulation, grasping, and dissection is performed.

THUNDERBEAT has not been shown to be effective for tubal sterilization and should not be used for these procedures.

For more information about Olympus' THUNDERBEAT  products visit www.olympusamerica.com/thunderbeat or contact your sales representative.

About Olympus Medical Systems

Olympus is a leader in the advancement of less invasive patient care. Olympus develops solutions for healthcare professionals that help improve outcomes and enhance the quality of life for their patients. By enabling minimally invasive procedures, innovative diagnostic and therapeutic endoscopy, and early-stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.

For more information about Olympus America, visit www.olympusamerica.com.


'/>"/>
SOURCE Olympus America Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Olympus Unveils New Dissolvable Post Sinus Surgery Products
2. Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles
3. Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection
4. Olympus Introduces Worlds First Autoclavable 5mm HD Deflectable Videolaparoscope
5. Olympus Biotech Names Oliver Burckhardt to President North America
6. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
7. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
8. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
9. Olympus Launches 2011 National Innovation Awards Program
10. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
11. Omnyx Licenses Olympus Digital Pathology Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
Breaking Medicine News(10 mins):